Why the study?
Cardiac fibrosis is a prevalent complication in diabetes, but the potential impact of diallyl trisulfide on cardiac fibrosis in the context of diabetes remains unknown.
Does Diallyl trisulfide (DATS) improve cardiac fibrosis and dysfunction in diabetic rat models?
Does Diallyl trisulfide (DATS) improve cardiac fibrosis and dysfunction in diabetic rat models?
DATS shows potential as a therapeutic agent for mitigating cardiac fibrosis and dysfunction associated with diabetic cardiomyopathy in preclinical models.
Answers are grounded in this paper and cite their sources.
DATS attenuates fibrosis in diabetic rat fibroblasts; hypothesis-generating for diabetic cardiomyopathy, requiring in vivo and clinical validation.
Cardiac fibrosis is a prevalent pathological complication observed in individuals with diabetes. Diallyl trisulfide (DATS), a bioactive compound found in garlic oil, has been reported to exhibit anti-inflammatory and anti-apoptotic effects in various cardiovascular diseases. However, its potential impact on cardiac fibrosis, particularly in the context of diabetes, remains unknown. In the neonatal rat ventricular fibroblasts (NRVFs) model, our results demonstrated that DATS effectively attenuated advanced glycation end products (AGEs)-induced activation of Nuclear factor kappa B (NF-κB) and Smad2/3 signaling pathways, leading to a reduction in the downstream secretion of pro-inflammatory cytokines and collagen synthesis. In the in vivo study using echocardiographic assessment, administration of DATS significantly ameliorated cardiac dysfunction induced by streptozotocin (STZ). Taken together, our findings highlight the potential of DATS as a promising therapeutic agent for mitigating cardiac fibrosis associated with diabetes, emphasizing its potential clinical relevance in the prevention and management of diabetic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Hsieh et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: